We have all been involved in cases regarding inventorship. Some of these situations can be either tricky or can be solved in a more fact-based manner. Research staff often don't know the difference between a co-author of an article and a co-inventor. This webinar drills down into the details of Defining Inventorship.
Are we also listening to the researchers? Do we really know what they think about our way of working? How do they perceive the information they get from us? Both presenters have been involved in knowledge transfer and commercialisation who share their views and impressions of the knowledge transfer process with us.
The development of new and improved varieties of plants benefits the economy by increasing the marketability of crops and improving rural income and overall economic development.
Most KTOs work with the spin-out route as a way of commercialising inventions from our research institutions: there are different models and policies in place at different KTOs. Marjan Kraak (Head of Spin-Off Group, ETH Transfer at ETH Zurich) take us through ETH Zurich's models and processes.
Ben Soffer, Head of Corporate Partnerships Kings College London presents ouon Corporate Partnerships.The MedTech Accelerator will act as a vehicle for the commercialisation of MedTech innovations. The Accelerator will be set up as a limited company based on a shareholder agreement and, in parallel, the parties are looking to facilitate the creation of a venture fund. The Accelerator has the ambition to position itself as the best place in the UK for MedTech Innovation to flourish successfully.
Andrew Katz will explore the dynamics of open technologies, and consider whether open hardware has the potential to be as successful as open source software.
In this webinar recording, Anja Zimmerman, discusses how knowledge and technology transfer can happen in numerous ways, from publication of research results to collaborations between scientist, between research organisations, between academia and industry or by creating companies.
Sometimes universities and research organisations fail to turn research results into marketable products or services, not because of lack of scientific excellence or technical innovativeness but, because of non-technological barriers such as economic, environmental, social, regulatory, or legal obstacles.
The ever-increasing digital transformation of our society and economy is bringing along the generation of a wealth of data with high value-add potential through the extraction of useful insights.
Frugal Innovation is the art of developing solutions by “doing more with less" creating more aggregate value for a client while reducing energy, waste, complexity, time and capital of a product. Hear Allan Báez Morales, Director of Programs and Partnerships at the Frugal Innovation Hub, University of Santa Clara, Ca.
Nagoya Protocol on Access and Benefit Sharing is an international agreement aimed at the fair and equitable sharing of benefits arising from the utilisation of genetic resources. Access and benefit-sharing obligations are established and negotiated between the country of origin and the researcher.
The pandemic prompted universities and public research organisations to re-think their IP management strategies. Various open licenses have been developed granting free temporary access to IP rights to tackle the coronavirus crisis. Do IPRs represent a barrier to access innovation in times of health emergencies?
Join our newsletter and get the latest news